Inclusion of the list of medicines reimbursed by National Insurance and approved for use by hospitals. .
-
Clinical Benefit
Substantial
The actual benefit of these drugs is substantial.
Clinical Added Value
minor
INOVELON offers a minor (level IV) improvement in actual benefit in the therapeutic management of patients aged 4 and over with Lennox-Gastaut syndrome that is resistant to first-line treatments.
Listen
